Mycoplasma hyorhinis -encoded cytidine deaminase efficiently inactivates cytosine-based anticancer drugs

Association of Mycoplasma hominis infection with prostate cancer

(2015) Yulia A. Barykova et al.   Oncotarget

An emerging understanding of the Janus face of the human microbiome: enhancement versus impairment of cancer therapy

(2014) J. Vande Voorde et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Nucleoside-catabolizing Enzymes in Mycoplasma-infected Tumor Cell Cultures Compromise the Cytostatic Activity of the Anticancer Drug Gemcitabine

(2014) Johan Vande Voorde et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases

(2013) Lars Petter Jordheim et al.   NATURE REVIEWS DRUG DISCOVERY

Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment

(2013) N. Iida et al.   SCIENCE

The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide

(2013) S. Viaud et al.   SCIENCE

Characterization of pyrimidine nucleoside phosphorylase ofMycoplasma hyorhinis: implications for the clinical efficacy of nucleoside analogues

(2012) Johan Vande Voorde et al.   BIOCHEMICAL JOURNAL

Can mycoplasma contribute to formation of prostate cancer?

(2012) Sakip M. Erturhan et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

Detection of antibodies directed at M. hyorhinis p37 in the serum of men with newly diagnosed prostate cancer

(2011) Cydney Urbanek et al.   BMC CANCER

Bacterial and fungal microflora in surgically removed lung cancer samples

(2011) Panagiotis Apostolou et al.   Journal of Cardiothoracic Surgery

Mycoplasma hyorhinisinfection in gastric carcinoma and its effects on the malignant phenotypes of gastric cancer cells

(2010) Hua Yang et al.   BMC GASTROENTEROLOGY

Influence of Cytidine Deaminase on Antitumor Activity of 2'-Deoxycytidine Analogs In Vitro and In Vivo

(2010) T. Yoshida et al.   DRUG METABOLISM AND DISPOSITION

Enzymology of Purine and Pyrimidine Antimetabolites Used in the Treatment of Cancer

(2009) William B. Parker   CHEMICAL REVIEWS

Improvement of purine and pyrimidine antimetabolite-based anticancer treatment by selective suppression of mycoplasma-encoded catabolic enzymes

(2009) Sandra Liekens et al.   LANCET ONCOLOGY

The cytostatic activity of pyrimidine nucleosides is strongly modulated by Mycoplasma hyorhinis infection: Implications for cancer therapy

(2008) Annelies Bronckaers et al.   BIOCHEMICAL PHARMACOLOGY